Management of medical products and vaccines during the pandemic of corona virus 2019 at Mahasarakham Province

Abstract

Objective : This study aimed to (1) investigate the lessons learned regarding the management of medicines medical supplies, and vaccines in Maha Sarakham, and (2) identify the problems encountered and solutions implemented during the pandemic.

Methods : This study employed face-to-face and in-depth interviews with stakeholders involved in the healthcare system and medical management during the pandemic. Stakeholders included health administrators, medical personnel, vaccine recipients, recovered COVID-19 patients, and patients with non-communicable diseases (NCDs). The study utilized the WHO Health System Building Blocks framework to design interview guides and conducted a content analysis of the qualitative interview data.

Results : The study identified three main themes: (1) policy and system management for controlling the COVID-19 outbreak, (2) the management of medical supplies, medicines, and vaccines, and (3) obstacles and solutions at each stage of the outbreak. Key issues included medication and vaccine shortages during peak periods, unequal vaccine distribution, and challenges in maintaining vaccine cold chain systems. Additionally, pharmaceutical care services were closed, leading to the implementation of telehealth and postal services for the delivery of medications for chronic NCDs. Due to the hospital's insufficient budget, financial support was obtained from external sources, private sectors, and donations to improve facilities and purchase necessary medical products and equipment. Despite challenges with inadequate medical staff, volunteers, including those from non-healthcare sectors and the public, provided support within hospitals and the community.

Conclusion : This study highlighted the challenges and facts surrounding the management and procurement of medical and non-medical supplies, as well as vaccines, during the pandemic. Recommendations for policymakers were proposed to improve resilience and preparedness for future global pandemics.